The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Epstein-Barr Virus and Systemic Autoimmune Diseases
Open accessAbstract
Epstein-Barr Virus (EBV) is an extremely successful human herpes virus, which infects essentially all human beings at some time during their life span. EBV infection and the associated immune response results in production of antibodies (seroconversion), which occurs mainly during the first years of life, but may also happen during adolescence or later in life. Infection of adolescents can result in infectious mononucleosis, an acute serious condition characterized by massive lymphocytosis. Transmission of EBV mainly occurs through saliva but can rarely be spread through semen or blood, e.g. through organ transplantations and blood transfusions. EBV transmission through oral secretions results in infection of epithelial cells of the oropharynx. From the epithelial cells EBV can infect B cells, which are the major reservoir for the virus, but other cell types may also become infected. As a result, EBV can shuttle between different cell types, mainly B cells and epithelial cells. Moreover, since the virus can switch between a latent and a lytic life cycle, EBV has the ability to cause chronic relapsing/reactivating infections. Chronic or recurrent EBV infection of epithelial cells has been linked to systemic lupus erythematosus and Sjögren’s syndrome, whereas chronic/recurrent infection of B cells has been associated with rheumatoid arthritis, multiple sclerosis and other diseases. Accordingly, since EBV can shuttle between epithelial cells and B cells, the systemic autoimmune diseases often occur as overlapping syndromes with symptoms and characteristic autoantibodies (e.g. antinuclear antibodies and rheumatoid factors) reflecting epithelial and/or B cell infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,778
Aringer, M., Costenbader, K., Daikh, D., Brinks, R., Mosca, M., Ramsey‐Goldman, R., Smolen, J. S., Wofsy, D., Boumpas, D. T., Kamen, D. L., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40930 · Cited by 2,677
Pathogenetic insights from the treatment of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31472-1 · Cited by 1,345
New insights into the immunopathogenesis of systemic lupus erythematosus
Tsokos, G. C., Lo, M. S., Reis, P. C., & Sullivan, K. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.186 · Cited by 1,226
Homology of Cytokine Synthesis Inhibitory Factor (IL-10) to the Epstein-Barr Virus Gene BCRFI
Moore, K. W., Vieira, P., Fiorentino, D. F., Trounstine, M. L., Khan, T. A., & Mosmann, T. R. (1990) · Science · doi:10.1126/science.2161559 · Cited by 1,143
(1948) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1948.tb28186.x · Cited by 1,141
The etiology of rheumatoid arthritis
Scherer, H. U., Häupl, T., & Burmester, G. R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102400 · Cited by 881
Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis
Arvin, A. M., Campadelli‐Fiume, G., Mocarski, E. S., Moore, P. S., Roizman, B., Whitley, R. J., & Yamanishi, K. (2007) · Cited by 844
Systemic lupus erythematosus: Diagnosis and clinical management
Fava, A., & Petri, M. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.11.001 · Cited by 754
Management strategies and future directions for systemic lupus erythematosus in adults
Durcan, L., O'Dwyer, T., & Petri, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30237-5 · Cited by 648
Farrell, P. J. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-013023 · Cited by 541
Primary Epstein-Barr virus infection
Dunmire, S. K., Verghese, P. S., & Balfour, H. H. (2018) · Journal of Clinical Virology · doi:10.1016/j.jcv.2018.03.001 · Cited by 520
SPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES
Kutok, J. L., & Wang, F. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100209 · Cited by 493
Latency and lytic replication in Epstein–Barr virus-associated oncogenesis
Münz, C. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0249-7 · Cited by 469
Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections
Odumade, O. A., Hogquist, K. A., & Balfour, H. H. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00044-10 · Cited by 458
Strategies toward rheumatoid arthritis therapy; the old and the new
Abbasi, M., Mousavi, M. J., Jamalzehi, S., Alimohammadi, R., Bezvan, M. H., Mohammadi, H., & Aslani, S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27860 · Cited by 443
Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry
McClain, M. T., Heinlen, L. D., Dennis, G. J., Roebuck, J., Harley, J. B., & James, J. A. (2005) · Nature Medicine · doi:10.1038/nm1167 · Cited by 441
An overview of autoantibodies in rheumatoid arthritis
van Delft, M. A. M., & Huizinga, T. W. J. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102392 · Cited by 398
Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis
(2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313 · Cited by 370
Yaniv, G., Twig, G., Shor, D. B.-A., Furer, A., Sherer, Y., Mozes, O., Komisar, O., Slonimsky, E., Klang, E., Lotan, E., et al. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.10.003 · Cited by 351
Molecular Diagnosis of Epstein-Barr Virus-Related Diseases
Gulley, M. L. (2001) · The Journal of Molecular Diagnostics · doi:10.1016/s1525-1578(10)60642-3 · Cited by 335
Serological diagnosis of Epstein-Barr virus infection: Problems and solutions
De Paschale, M. (2012) · World Journal of Virology · doi:10.5501/wjv.v1.i1.31 · Cited by 333
Hutt-Fletcher, L. M. (2007) · Journal of Virology · doi:10.1128/jvi.00445-07 · Cited by 323
Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus
Poole, B. D., Scofield, R. H., Harley, J. B., & James, J. A. (2006) · Autoimmunity · doi:10.1080/08916930500484849 · Cited by 286
Biology and disease associations of Epstein–Barr virus
Crawford, D. H. (2001) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2000.0783 · Cited by 285
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
Bar-Or, A., Pender, M. P., Khanna, R., Steinman, L., Hartung, H.-P., Maniar, T., Croze, E., Aftab, B. T., Giovannoni, G., & Joshi, M. A. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.11.003 · Cited by 262
Alonso-Ruiz, A., Pijoan, J. I., Ansuategui, E., Urkaregi, A., Calabozo, M., & Quintana, A. (2008) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-9-52 · Cited by 250
Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry
Zhang, H., Li, Y., Wang, H.-B., Zhang, A., Chen, M.-L., Fang, Z.-X., Dong, X.-D., Li, S.-B., Du, Y., Xiong, D., et al. (2018) · Nature Microbiology · doi:10.1038/s41564-017-0080-8 · Cited by 248
Environmental exposures and the development of systemic lupus erythematosus
Barbhaiya, M., & Costenbader, K. H. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000318 · Cited by 241
Rowe, M., Glaunsinger, B., van Leeuwen, D., Zuo, J., Sweetman, D., Ganem, D., Middeldorp, J., Wiertz, E. J. H. J., & Ressing, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611128104 · Cited by 240
Epstein-Barr Virus in Systemic Autoimmune Diseases
Draborg, A. H., Duus, K., & Houen, G. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/535738 · Cited by 232
Self-citationImmunogenetics of systemic lupus erythematosus: A comprehensive review
Ghodke-Puranik, Y., & Niewold, T. B. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.004 · Cited by 225
Hatton, O. L., Harris-Arnold, A., Schaffert, S., Krams, S. M., & Martinez, O. M. (2014) · Immunologic Research · doi:10.1007/s12026-014-8496-1 · Cited by 216
Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells
Wang, H.-B., Zhang, H., Zhang, J.-P., Li, Y., Zhao, B., Feng, G.-K., Du, Y., Xiong, D., Zhong, Q., Liu, W.-L., et al. (2015) · Nature Communications · doi:10.1038/ncomms7240 · Cited by 215
Understanding the role of environmental factors in the development of systemic lupus erythematosus
Parks, C. G., de Souza Espindola Santos, A., Barbhaiya, M., & Costenbader, K. H. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.09.005 · Cited by 214
Impaired clearance of dying cells in systemic lupus erythematosus
Gaipl, U. S., Voll, R. E., Sheriff, A., Franz, S., Kalden, J. R., & Herrmann, M. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.10.007 · Cited by 213
Ephrin receptor A2 is a functional entry receptor for Epstein–Barr virus
Chen, J., Sathiyamoorthy, K., Zhang, X., Schaller, S., Perez White, B. E., Jardetzky, T. S., & Longnecker, R. (2018) · Nature Microbiology · doi:10.1038/s41564-017-0081-7 · Cited by 210
Epstein-Barr virus (EBV) reactivation and therapeutic inhibitors
Kerr, J. R. (2019) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2019-205822 · Cited by 206
Zuo, J., Currin, A., Griffin, B. D., Shannon-Lowe, C., Thomas, W. A., Ressing, M. E., Wiertz, E. J. H. J., & Rowe, M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000255 · Cited by 204
Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology
Volkov, M., van Schie, K. A., & van der Woude, D. (2020) · Immunological Reviews · doi:10.1111/imr.12829 · Cited by 201
Epstein‐Barr virus strain variation and cancer
Kanda, T., Yajima, M., & Ikuta, K. (2019) · Cancer Science · doi:10.1111/cas.13954 · Cited by 197
Hislop, A. D., Ressing, M. E., van Leeuwen, D., Pudney, V. A., Horst, D., Koppers-Lalic, D., Croft, N. P., Neefjes, J. J., Rickinson, A. B., & Wiertz, E. J. H. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070256 · Cited by 189
The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis
Pender, M. P. (2010) · The Neuroscientist · doi:10.1177/1073858410381531 · Cited by 186
Dunmire, S. K., Hogquist, K. A., & Balfour, H. H. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-319-22822-8_9 · Cited by 186
Epstein-Barr Virus and Systemic Lupus Erythematosus
Draborg, A., Duus, K., & Houen, G. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/370516 · Cited by 182
Self-citationImmune Evasion by Epstein-Barr Virus
Ressing, M. E., van Gent, M., Gram, A. M., Hooykaas, M. J. G., Piersma, S. J., & Wiertz, E. J. H. J. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_12 · Cited by 182
The genetics of rheumatoid arthritis
Dedmon, L. E. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa232 · Cited by 179
Lam, W. K. J., Jiang, P., Chan, K. C. A., Cheng, S. H., Zhang, H., Peng, W., Tse, O. Y. O., Tong, Y. K., Gai, W., Zee, B. C. Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804184115 · Cited by 171
Primary Epstein-Barr virus infection with and without infectious mononucleosis
Rostgaard, K., Balfour, H. H., Jarrett, R., Erikstrup, C., Pedersen, O., Ullum, H., Nielsen, L. P., Voldstedlund, M., & Hjalgrim, H. (2019) · PLOS ONE · doi:10.1371/journal.pone.0226436 · Cited by 161
Update on the Genetics of Systemic Lupus Erythematosus: Genome-Wide Association Studies and Beyond
Kwon, Y.-C., Chun, S., Kim, K.-W., & Mak, A. (2019) · Cells · doi:10.3390/cells8101180 · Cited by 154
Helminen, M., Lahdenpohja, N., & Hurme, M. (1999) · The Journal of Infectious Diseases · doi:10.1086/314883 · Cited by 151
Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases
Willrich, M. A. V., Murray, D. L., & Snyder, M. R. (2014) · Translational research · doi:10.1016/j.trsl.2014.09.006 · Cited by 148
van Gent, M., Braem, S., de Jong, A., Delagic, N., Peeters, J. G. C., Boer, I. G. J., Moynagh, P. N., Kremmer, E., Wiertz, E. J. H. J., Ovaa, H., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003960 · Cited by 145
Latour, S., & Fischer, A. (2019) · Immunological Reviews · doi:10.1111/imr.12791 · Cited by 139
Islam, M. A., Khandker, S. S., Alam, S. S., Kotyla, P. J., & Hassan, R. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102392 · Cited by 139
Klareskog, L., Rönnelid, J., Saevarsdóttir, S., Padyukov, L., & Alfredsson, L. S. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13058 · Cited by 138
Salek‐Ardakani, S., Arrand, J. R., & Mackett, M. (2002) · Virology · doi:10.1006/viro.2002.1716 · Cited by 124
Croia, C., Serafini, B., Bombardieri, M., Kelly, S., Humby, F., Severa, M., Rizzo, F., Coccia, E. M., Migliorini, P., Aloisi, F., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202352 · Cited by 123
Epstein-Barr virus-encoded microRNAs as regulators in host immune responses
Wang, M., Yu, F., Wu, W., Wang, Y., Ding, H., & Qian, L. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.24562 · Cited by 122
Epstein-Barr virus latency: current and future perspectives
Kempkes, B., & Robertson, E. S. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.09.007 · Cited by 121
Epstein-Barr virus and rheumatoid arthritis
Balandraud, N., & Roudier, J. (2017) · Joint Bone Spine · doi:10.1016/j.jbspin.2017.04.011 · Cited by 118
Early environmental factors and rheumatoid arthritis
Edwards, C. J., & Cooper, C. C. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02940.x · Cited by 117
Epstein–Barr Virus: Diseases Linked to Infection and Transformation
Jha, H. C., Pei, Y., & Robertson, E. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01602 · Cited by 116
The T-cell Response to Epstein-Barr Virus–New Tricks From an Old Dog
Long, H. M., Meckiff, B. J., & Taylor, G. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02193 · Cited by 115
Epigenetic lifestyle of Epstein-Barr virus
Buschle, A., & Hammerschmidt, W. (2020) · Seminars in Immunopathology · doi:10.1007/s00281-020-00792-2 · Cited by 114
Sathiyamoorthy, K., Hu, Y. X., Möhl, B. S., Chen, J., Longnecker, R., & Jardetzky, T. S. (2016) · Nature Communications · doi:10.1038/ncomms13557 · Cited by 113
Ressing, M. E., van Leeuwen, D., Verreck, F. A. W., Gomez, R., Heemskerk, B., Toebes, M., Mullen, M. M., Jardetzky, T. S., Longnecker, R., Schilham, M. W., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2034960100 · Cited by 111
Host genetics of Epstein–Barr virus infection, latency and disease
Houldcroft, C. J., & Kellam, P. (2014) · Reviews in Medical Virology · doi:10.1002/rmv.1816 · Cited by 108
Infections and systemic lupus erythematosus
Esposito, S., Bosis, S., Semino, M., & Rigante, D. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2098-7 · Cited by 107
Environmental factors in the pathogenesis of primary Sjögren's syndrome
Björk, A., Mofors, J., & Wahren‐Herlenius, M. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13032 · Cited by 106
BFRF1 of Epstein-Barr Virus Is Essential for Efficient Primary Viral Envelopment and Egress
Farina, A., Feederle, R., Raffa, S., Gonnella, R., Santarelli, R., Frati, L., Angeloni, A., Torrisi, M. R., Faggioni, A., & Delecluse, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3703-3712.2005 · Cited by 105
Xiong, D., Du, Y., Wang, H., Zhao, B., Zhang, H., Li, Y., Hu, L.-J., Cao, J.-Y., Zhong, Q., Liu, W.-L., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513359112 · Cited by 103
Ressing, M. E., van Leeuwen, D., Verreck, F. A. W., Keating, S. E., Gomez, R., Franken, K. L. M. C., Ottenhoff, T. H. M., Spriggs, M. K., Schumacher, T. N., Hutt‐Fletcher, L. M., et al. (2004) · Journal of Virology · doi:10.1128/jvi.79.2.841-852.2005 · Cited by 103
Wilson, J. B., Manet, É., Gruffat, H., Busson, P., Blondel, M., & Fåhræus, R. (2018) · Cancers · doi:10.3390/cancers10040109 · Cited by 101
Mehraein, Y., Lennerz, C., Ehlhardt, S., REMBERGER, K., Ojak, A., & Zang, K. D. (2004) · Modern Pathology · doi:10.1038/modpathol.3800119 · Cited by 98
Human inborn errors of immunity to herpes viruses
Jouanguy, E., Béziat, V., Mogensen, T. H., Casanova, J., Tangye, S. G., & Zhang, S. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.01.004 · Cited by 97
Quinn, L. L., Williams, L. R., White, C., Forrest, C., Zuo, J., & Rowe, M. (2015) · Journal of Virology · doi:10.1128/jvi.02183-15 · Cited by 94
Dynamic Epstein–Barr Virus Gene Expression on the Path to B-Cell Transformation
Price, A. M., & Luftig, M. A. (2014) · Advances in virus research · doi:10.1016/b978-0-12-800098-4.00006-4 · Cited by 93
The Epstein–Barr virus BMRF-2 protein facilitates virus attachment to oral epithelial cells
Xiao, J., Palefsky, J. M., Herrera, R., Berline, J. W., & Tugizov, S. M. (2007) · Virology · doi:10.1016/j.virol.2007.09.012 · Cited by 93
A Surfeit of Factors: Why is Ribosome Assembly So Much More Complicated in Eukaryotes than Bacteria?
Hage, A. E., & Tollervey, D. W. (2004) · RNA Biology · doi:10.4161/rna.1.1.932 · Cited by 89
Gan, Y. J., Chodosh, J., Morgan, A. J., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.519-526.1997 · Cited by 88
The Infectious Basis of ACPA-Positive Rheumatoid Arthritis
Sakkas, L. I., Daoussis, D., Liossis, S. C., & Bogdanos, D. P. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01853 · Cited by 86
Epithelial cell infection by Epstein–Barr virus
Chen, J., & Longnecker, R. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz023 · Cited by 83
Granato, M., Feederle, R., Farina, A., Gonnella, R., Santarelli, R., Hub, B., Faggioni, A., & Delecluse, H. (2008) · Journal of Virology · doi:10.1128/jvi.02436-07 · Cited by 82
Innate immune responses against Epstein Barr virus infection
Chijioke, O., Azzi, T., Nadal, D., & Münz, C. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313173 · Cited by 81
gH/gL supercomplexes at early stages of herpesvirus entry
Heldwein, E. E. Z. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.01.010 · Cited by 81
Immunoglobulin G structure and rheumatoid factor epitopes
Maibom-Thomsen, S., Trier, N. H., Holm, B. E., Hansen, K. B., Rasmussen, M. I., Chailyan, A., Marcatili, P., Højrup, P., & Houen, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217624 · Cited by 81
Self-citationMicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity
Albanese, M., Tagawa, T., Buschle, A., & Hammerschmidt, W. (2017) · Journal of Virology · doi:10.1128/jvi.01667-16 · Cited by 80
Nakamura, H., Kawakami, A., & Eguchi, K. (2006) · Translational research · doi:10.1016/j.trsl.2006.07.003 · Cited by 79
Assessment of disease activity in Systemic Lupus Erythematosus: Lights and shadows
Ceccarelli, F., Perricone, C., Massaro, L., Cipriano, E., Alessandri, C., Spinelli, F. R., Valesini, G., & Conti, F. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.02.008 · Cited by 77
The relationships between cancer and autoimmune rheumatic diseases
Cappelli, L. C., & Shah, A. A. (2020) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2019.101472 · Cited by 77
The Role of Gamma Delta T Cells in Autoimmune Rheumatic Diseases
Bank, I. (2020) · Cells · doi:10.3390/cells9020462 · Cited by 77
Epstein–Barr Virus and Innate Immunity: Friends or Foes?
Jangra, S., Yuen, K., Botelho, M. G., & Jin, D. (2019) · Microorganisms · doi:10.3390/microorganisms7060183 · Cited by 74
Epstein-Barr Virus-Specific Humoral Immune Responses in Health and Disease
Middeldorp, J. M. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_10 · Cited by 72
The role of Epstein–Barr virus infection in primary Sjögren's syndrome
Maślińska, M. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000622 · Cited by 72
Genetics of Sjögren's syndrome
Teos, L. Y., & Alevizos, I. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.04.018 · Cited by 71
Evolving story of autoantibodies in systemic lupus erythematosus
Pisetsky, D. S. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102356 · Cited by 70
Epstein Barr Virus Interleukin 10 Suppresses Anti-inflammatory Phenotype in Human Monocytes
Jog, N. R., Chakravarty, E. F., Guthridge, J. M., & James, J. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02198 · Cited by 69
Parisis, D., Bernier, C., Chasset, F., & Arnaud, L. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102393 · Cited by 68
Interplay of Infections, Autoimmunity, and Immunosuppression in Systemic Lupus Erythematosus
Caza, T. N., Oaks, Z., & Perl, A. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2013.863305 · Cited by 67
Ball, R. J., Avenell, A., Aucott, L. S., Hanlon, P., & Vickers, M. A. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0755-6 · Cited by 66
Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus
Möhl, B. S., Chen, J., Sathiyamoorthy, K., Jardetzky, T. S., & Longnecker, R. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.0066 · Cited by 65
Comparative virion structures of human herpesviruses
Liu, F., & Zhou, Z. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.004 · Cited by 64
The genetics of scleroderma (systemic sclerosis)
Agarwal, S. K., & Reveille, J. D. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283367c17 · Cited by 63
Reactivation and lytic replication of KSHV
Lukac, D. M., & Yuan, Y. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.027 · Cited by 62
Rowe, M., & Zuo, J. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.12.001 · Cited by 61
Obesity interacts with infectious mononucleosis in risk of multiple sclerosis
Hedström, A. K., Bomfim, I. L., Hillert, J. A., Olsson, T. P., & Alfredsson, L. S. (2014) · European Journal of Neurology · doi:10.1111/ene.12620 · Cited by 61
Reduced response to Epstein–Barr virus antigens by T-cells in systemic lupus erythematosus patients
Draborg, A. H., Jacobsen, S., Westergaard, M. C. W., Mortensen, S., Larsen, J. L., Houen, G., & Duus, K. (2014) · Lupus Science & Medicine · doi:10.1136/lupus-2014-000015 · Cited by 61
Self-citationEpstein–Barr Virus-Specific Immune Control by Innate Lymphocytes
Münz, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01658 · Cited by 61
Flåm, S. T., Gunnarsson, R., Garen, T., et al. (2014) · Lara D. Veeken · doi:10.1093/rheumatology/keu310 · Cited by 60
Reactivation and lytic replication of EBV
Kenney, S. C. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.026 · Cited by 60
The Epigenetic Life Cycle of Epstein–Barr Virus
Hammerschmidt, W. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22822-8_6 · Cited by 57
Comparison of plasma vitamin D levels in patients with Sjögren's syndrome and healthy subjects
Erten, Ş., Şahin, A., Altunoğlu, A., Gemcioğlu, E., & Koca, C. (2014) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12298 · Cited by 56
EBV Glycoproteins: Where are we now?
Hutt‐Fletcher, L. M. (2015) · Future Virology · doi:10.2217/fvl.15.80 · Cited by 53
Anti-dsDNA Antibodies are one of the many autoantibodies in systemic lupus erythematosus
Fu, S. M., Dai, C., Zhao, Z., & Gaskin, F. (2015) · F1000Research · doi:10.12688/f1000research.6875.1 · Cited by 51
Sakamoto, K., Sekizuka, T., Uehara, T., Hishima, T., Mine, S., Fukumoto, H., Sato, Y., Hasegawa, H., Kuroda, M., & Katano, H. (2017) · Cancer Medicine · doi:10.1002/cam4.1006 · Cited by 51
Myeloid Populations in Systemic Autoimmune Diseases
Morell, M. H., Varela, N., & Marañón, C. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8606-7 · Cited by 49
Daskalogianni, C., Pyndiah, S., Apcher, S., Mazars, A., Manoury, B., Ammari, N., Nylander, K., Voisset, C., Blondel, M., & Fåhræus, R. (2014) · The Journal of Pathology · doi:10.1002/path.4431 · Cited by 48
Schiffenbauer, A. I., Faghihi‐Kashani, S., O'Hanlon, T. P., Flegel, W. A., Adams, S. D., Targoff, I. N., Oddis, C. V., Ytterberg, S. R., Aggarwal, R., Christopher‐Stine, L., et al. (2018) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2018.02.003 · Cited by 47
Infections as a cause of autoimmune rheumatic diseases
Sakkas, L. I., & Bogdanos, D. P. (2016) · Autoimmunity Highlights · doi:10.1007/s13317-016-0086-x · Cited by 46
Structural genomics of the Epstein–Barr virus
Tarbouriech, N., Buisson, M., Géoui, T., Daenke, S., Cusack, S., & Burmeister, W. P. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906030034 · Cited by 44
Diagnosis of Epstein-Barr virus-related diseases.
Linde, A. (1996) · PubMed · Cited by 42
Elegheert, J., Bracke, N., Pouliot, P., Gutsche, I., Shkumatov, A. V., Tarbouriech, N., Verstraete, K., Bekaert, A., Burmeister, W. P., Svergun, D. I., et al. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2367 · Cited by 41
Yoon, S. I., Jones, B. C., Logsdon, N. J., Harris, B. D., Kuruganti, S., & Walter, M. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.376707 · Cited by 40
Trier, N. H., Izarzugaza, J. M. G., Chailyan, A., Marcatili, P., & Houen, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010317 · Cited by 39
Self-citationRevisiting the complement system in systemic lupus erythematosus
Sharma, M., Vignesh, P., Tiewsoh, K., & Rawat, A. K. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1745063 · Cited by 39
Anti–B Cell Antibody Therapies for Inflammatory Rheumatic Diseases
Faurschou, M., & Jayne, D. R. W. (2013) · Annual Review of Medicine · doi:10.1146/annurev-med-070912-133235 · Cited by 38
Update on rheumatic manifestations of infectious diseases
Becker, J., & Winthrop, K. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328333b9f5 · Cited by 35
Herpesviridae and novel inhibitors
Siakallis, G., Spandidos, D. A., & Sourvinos, G. (2009) · Antiviral Therapy · doi:10.3851/imp1467 · Cited by 34
Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients
Draborg, A. H., Sandhu, N., Larsen, N., Larsen, J. L., Jacobsen, S., & Houen, G. (2016) · Journal of Immunology Research · doi:10.1155/2016/6473204 · Cited by 34
Self-citationSternbæk, L., Draborg, A. H., Østerlund, M. T., Iversen, L. V., Troelsen, L. N., Theander, E., Nielsen, C. T., Jacobsen, S., & Houen, G. (2019) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2018.1550807 · Cited by 34
Self-citationColombini, A., Ragni, E., Mortati, L., Libonati, F., Orfei, C. P., Viganò, M., Brayda‐Bruno, M., & de Girolamo, L. (2021) · Cells · doi:10.3390/cells10051180 · Cited by 32
Hoebe, E. K., Large, T. Y. S. L., Tarbouriech, N., Oosterhoff, D., de Gruijl, T. D., Middeldorp, J. M., & Greijer, A. E. (2012) · Viral Immunology · doi:10.1089/vim.2012.0034 · Cited by 31
Increased levels of Epstein‐Barr virus DNA in lacrimal glands of Sjögren's syndrome patients
Tsubota, K., Fujishima, H., Toda, I., Katagiri, S., KAWASHIMA, Y., & Saito, I. (1995) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.1995.tb00302.x · Cited by 30
Masuoka, S., Kusunoki, N., Takamatsu, R., Takahashi, H., Tsuchiya, K., Kawai, S., & Nanki, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208957 · Cited by 30
Epstein-Barr virus infection mechanisms
Chesnokova, L. S., & Hutt‐Fletcher, L. M. (2014) · 癌症:英文版 · doi:10.5732/cjc.014.10168 · Cited by 29
A Genome-Wide Epstein-Barr Virus Polyadenylation Map and Its Antisense RNA to EBNA
Majerčiak, V., Yang, W., Zheng, J., Zhu, J., & Zheng, Z. (2018) · Journal of Virology · doi:10.1128/jvi.01593-18 · Cited by 23
Human gammaherpesvirus immune evasion strategies
Means, R. E., Lang, S. M., & Jung, J. U. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.032 · Cited by 20
Servioli, L., Maciel, G., Nannini, C., Crowson, C. S., Matteson, E. L., Cornec, D., & Berti, A. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.180481 · Cited by 20
Gammaherpesvirus maintenance and replication during latency
Lieberman, P. M., Hu, J., & Renne, R. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.025 · Cited by 17
Cytomegalovirus infection in pediatric rheumatic diseases: a review
Eisenstein, E. M., & Wolf, D. G. (2010) · Pediatric Rheumatology · doi:10.1186/1546-0096-8-17 · Cited by 17
Prado, M. S., Dellavance, A., Rodrigues, S. H., Marvulle, V., & Andrade, L. E. C. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2019-0638 · Cited by 17
Emerging Viral Infections in Rheumatic Diseases
Khasnis, A. A., Schoen, R. T., & Calabrese, L. H. (2011) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2011.01.008 · Cited by 16
Cited by
Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
Gold, J. E., Okyay, R. A., Licht, W. E., & Hurley, D. J. (2021) · Pathogens · doi:10.3390/pathogens10060763 · Cited by 371
Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study
Chang, R., Yen-Ting Chen, T., Wang, S.-I., Hung, Y.-M., Chen, H.-Y., & Wei, C.-C. J. (2023) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101783 · Cited by 308
Song, Y., Li, J., & Wu, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01952-8 · Cited by 259
Chronic viral coinfections differentially affect the likelihood of developing long COVID
Peluso, M. J., Deveau, T.-M., Munter, S. E., Ryder, D., Buck, A., Beck-Engeser, G., Chan, F., Lu, S., Goldberg, S. A., Hoh, R., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163669 · Cited by 254
Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications
Bjornevik, K., Münz, C., Cohen, J. I., & Ascherio, A. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00775-5 · Cited by 246
Metadata
- Authors
- Houen, G., & Trier, N. H.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2021-01-07
- Volume
- 11
- Pages
- 587380-587380
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3118775651
- Cited by
- 379
- References
- 144
- FWCI
- 20.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.